Fatty liver disease and changes in dense breasts in pre- and postmenopausal women: the Kangbuk Samsung Health Study.
Cohort study
Dense breast
Mammogram
Mammographic breast density
Persistent dense breast
Resolution of dense breast
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
23
02
2021
accepted:
29
07
2021
pubmed:
17
9
2021
medline:
3
11
2021
entrez:
16
9
2021
Statut:
ppublish
Résumé
While increased breast density is a risk factor for breast cancer, the effect of fatty liver disease on breast density is unknown. We investigated whether fatty liver is a risk factor for changes in breast density over ~ 4 years of follow-up in pre- and postmenopausal women. This study included 74,781 middle-aged Korean women with mammographically determined dense breasts at baseline. Changes in dense breasts were identified by more screening mammograms during follow-up. Hepatic steatosis (HS) was measured using ultrasonography. Flexible parametric proportional hazards models were used to determine the adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs), and a Weibull accelerated failure time model (AFT) was used to determine the time ratios (TRs) and 95% CIs. During a median follow-up of 4.1 years, 4022 women experienced resolution of the dense breasts. The association between HS and dense breast resolution differed by the menopause status (P for interaction < 0.001). After adjusting for body mass index and other covariates, the aHRs (95% CI) for dense breast resolution comparing HS to non-HS were 0.81 (0.70-0.93) in postmenopausal women, while the association was converse in premenopausal women with the corresponding HRs of 1.30 (1.18-1.43). As an alternative approach, the multivariable-adjusted TR (95% CI) for dense breast survival comparing HS to non-HS were 0.81 (0.75-0.87) and 1.19 (1.06-1.33) in premenopausal and postmenopausal women, respectively. The association between HS and changes in dense breasts differed with the menopause status. HS increased persistent dense breast survival in postmenopausal women but decreased it in premenopausal women.
Identifiants
pubmed: 34529194
doi: 10.1007/s10549-021-06349-7
pii: 10.1007/s10549-021-06349-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-353Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2017R1A2B2008401
Organisme : National Research Foundation of Korea
ID : NFR-2021R1A2C1014363
Organisme : Southampton National Institute for Health Research Biomedical Research Centre
ID : IS-BRC-20004
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313(22):2263–2273
pubmed: 26057287
doi: 10.1001/jama.2015.5370
pmcid: 26057287
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129(1):113–121
pubmed: 16012941
doi: 10.1053/j.gastro.2005.04.014
pmcid: 16012941
Kim GA, Lee HC, Choe J, Kim MJ, Lee MJ, Chang HS, Bae IY, Kim HK, An J, Shim JH et al (2017) Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol
Sanna C, Rosso C, Marietti M, Bugianesi E (2016) Non-alcoholic fatty liver disease and extra-hepatic cancers. Int J Mol Sci 17(5)
Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM (2019) The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity—a longitudinal cohort study. J Hepatol 71(6):1229–1236
pubmed: 31470068
pmcid: 6921701
doi: 10.1016/j.jhep.2019.08.018
Yamamoto K, Ikeya T, Okuyama S, Fukuda K, Kobayashi D (2020) The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development. J Gastroenterol Hepatol
Youlden DR, Cramb SM, Yip CH, Baade PD (2014) Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 11(2):101–115
pubmed: 25009752
pmcid: 4069805
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
doi: 10.3322/caac.21492
Mantovani A, Petracca G, Beatrice G, Csermely A, Tilg H, Byrne CD, Targher G (2021) Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut
Park JH, Choi IS, Han KD, Park H, Kim KH, Kim JS (2020) Association between fatty liver index and risk of breast cancer: a nationwide population-based study. Clin Breast Cancer 20(4):e450–e457
pubmed: 32192863
doi: 10.1016/j.clbc.2020.02.004
pmcid: 32192863
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O’Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA et al (2018) Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol 4(11):e181771
pubmed: 29931120
pmcid: 6248078
doi: 10.1001/jamaoncol.2018.1771
Chen Y, Liu L, Zhou Q, Imam MU, Cai J, Wang Y, Qi M, Sun P, Ping Z, Fu X (2017) Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. BMC Public Health 17(1):936
pubmed: 29216920
pmcid: 5721381
doi: 10.1186/s12889-017-4953-9
Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S (2010) Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 102(16):1224–1237
pubmed: 20616353
pmcid: 2923218
doi: 10.1093/jnci/djq239
Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13(6):223
pubmed: 22114898
pmcid: 3326547
doi: 10.1186/bcr2942
McCormack VA, dos Santos SI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169
pubmed: 16775176
doi: 10.1158/1055-9965.EPI-06-0034
pmcid: 16775176
Azam S, Eriksson M, Sjolander A, Hellgren R, Gabrielson M, Czene K, Hall P (2020) Mammographic Density Change and Risk of Breast Cancer. J Natl Cancer Inst 112(4):391–399
pubmed: 31298705
doi: 10.1093/jnci/djz149
pmcid: 31298705
Azam S, Sjolander A, Eriksson M, Gabrielson M, Czene K, Hall P (2019) Determinants of mammographic density change. JNCI Cancer Spectr 3(1):pkz004
pubmed: 31360892
pmcid: 6649843
doi: 10.1093/jncics/pkz004
Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) National Institutes of Health Breast Cancer Surveillance C: Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99(5):386–395
pubmed: 17341730
doi: 10.1093/jnci/djk066
pmcid: 17341730
Kim EY, Chang Y, Ahn J, Yun JS, Park YL, Park CH, Shin H, Ryu S (2020) Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women. Cancer
Lokate M, Stellato RK, Veldhuis WB, Peeters PH, van Gils CH (2013) Age-related changes in mammographic density and breast cancer risk. Am J Epidemiol 178(1):101–109
pubmed: 23703889
doi: 10.1093/aje/kws446
pmcid: 23703889
Jo HM, Lee EH, Ko K, Kang BJ, Cha JH, Yi A, Jung HK, Jun JK (2019) Prevalence of women with dense breasts in Korea: results from a nationwide cross-sectional study. Cancer Res Treat 51(4):1295–1301
pubmed: 30699499
pmcid: 6790853
doi: 10.4143/crt.2018.297
Youn I, Choi S, Kook SH, Choi YJ (2016) Mammographic breast density evaluation in korean women using fully automated volumetric assessment. J Korean Med Sci 31(3):457–462
pubmed: 26955249
pmcid: 4779873
doi: 10.3346/jkms.2016.31.3.457
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ (2012) Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97(4):1159–1168
pubmed: 22344196
pmcid: 3319184
doi: 10.1210/jc.2011-3362
Fernandez-Sola J (2015) Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol 12(10):576–587
pubmed: 26099843
doi: 10.1038/nrcardio.2015.91
pmcid: 26099843
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395
pubmed: 12900694
doi: 10.1249/01.MSS.0000078924.61453.FB
pmcid: 12900694
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213
pubmed: 2748771
pmcid: 2748771
doi: 10.1016/0165-1781(89)90047-4
American College of Radiology, BI-RADS Committee (2013) ACR BI-RADS® atlas: breast imaging reporting and data system, 5th edn. American College of Radiology, Reston
Freer PE (2015) Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 35(2):302–315
pubmed: 25763718
doi: 10.1148/rg.352140106
pmcid: 25763718
Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, Foberg U, Fryden A, Bodemar G (2002) Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34(7):516–522
pubmed: 12236486
doi: 10.1016/S1590-8658(02)80111-6
pmcid: 12236486
Chang Y, Ryu S, Sung KC, Cho YK, Sung E, Kim HN, Jung HS, Yun KE, Ahn J, Shin H et al (2018) Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut 68(9):1667–1675
pubmed: 30472683
doi: 10.1136/gutjnl-2018-317666
pmcid: 30472683
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45(4):846–854
pubmed: 17393509
doi: 10.1002/hep.21496
pmcid: 17393509
Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ (2009) Nash Clinical Research N: Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7(10):1104–1112
pubmed: 19523535
pmcid: 3079239
doi: 10.1016/j.cgh.2009.05.033
Royston P, Parmar MK (2002) Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21(15):2175–2197
pubmed: 12210632
doi: 10.1002/sim.1203
pmcid: 12210632
Vallurupalli M, MacFadyen JG, Glynn RJ, Thuren T, Libby P, Berliner N, Ridker PM (2020) Effects of Interleukin-1beta inhibition on incident anemia: exploratory analyses from a randomized trial. Ann Intern Med 172(8):523–532
pubmed: 32203978
pmcid: 7980674
doi: 10.7326/M19-2945
Gregson J, Sharples L, Stone GW, Burman CF, Ohrn F, Pocock S (2019) Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week. J Am Coll Cardiol 74(16):2102–2112
pubmed: 31623769
doi: 10.1016/j.jacc.2019.08.1034
pmcid: 31623769
Soguel L, Durocher F, Tchernof A, Diorio C (2017) Adiposity, breast density, and breast cancer risk: epidemiological and biological considerations. Eur J Cancer Prev 26(6):511–520
pubmed: 27571214
pmcid: 5627530
doi: 10.1097/CEJ.0000000000000310
Kwak MS, Yim JY, Yi A, Chung GE, Yang JI, Kim D, Kim JS, Noh DY (2019) Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women. Dig Liver Dis 51(7):1030–1035
pubmed: 30686716
doi: 10.1016/j.dld.2018.12.024
pmcid: 30686716
Kim BK, Chang Y, Ahn J, Jung HS, Kim CW, Yun KE, Kwon MJ, Suh BS, Chung EC, Shin H et al (2015) Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women. Breast Cancer Res Treat 153(2):425–434
pubmed: 26277917
doi: 10.1007/s10549-015-3544-7
pmcid: 26277917
Rice MS, Bertrand KA, VanderWeele TJ, Rosner BA, Liao X, Adami HO, Tamimi RM (2016) Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res 18(1):94
pubmed: 27654859
pmcid: 5031307
doi: 10.1186/s13058-016-0750-0
Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ et al (2018) Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat 170(1):129–141
pubmed: 29502324
pmcid: 5994184
doi: 10.1007/s10549-018-4735-9
Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, Ma L, Shepherd J, Tice JA, Mahmoudzadeh AP et al (2015) The effect of change in body mass index on volumetric measures of mammographic density. Cancer Epidemiol Biomarkers Prev 24(11):1724–1730
pubmed: 26315554
pmcid: 4633314
doi: 10.1158/1055-9965.EPI-15-0330
Baglietto L, Krishnan K, Stone J, Apicella C, Southey MC, English DR, Hopper JL, Giles GG (2014) Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol 179(4):475–483
pubmed: 24169466
doi: 10.1093/aje/kwt260
pmcid: 24169466
Conroy SM, Butler LM, Harvey D, Gold EB, Sternfeld B, Greendale GA, Habel LA (2011) Metabolic syndrome and mammographic density: the Study of Women’s Health Across the Nation. Int J Cancer 129(7):1699–1707
pubmed: 21105041
pmcid: 3610563
doi: 10.1002/ijc.25790
Nelson LR, Bulun SE (2001) Estrogen production and action. J Am Acad Dermatol 45(3 Suppl):S116-124
pubmed: 11511861
doi: 10.1067/mjd.2001.117432
pmcid: 11511861
Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE (1994) Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 171(1):171–177
pubmed: 8030695
doi: 10.1016/0002-9378(94)90465-0
pmcid: 8030695
Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88(11):756–758
pubmed: 8637031
doi: 10.1093/jnci/88.11.756
pmcid: 8637031
Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, Uribe M, Mendez-Sanchez N (2010) Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 9(4):402–409
pubmed: 21057159
doi: 10.1016/S1665-2681(19)31616-3
pmcid: 21057159
Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ (2007) Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92(8):3040–3043
pubmed: 17519304
doi: 10.1210/jc.2007-0581
pmcid: 17519304
Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W (2004) Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol 183(2):331–342
pubmed: 15531721
doi: 10.1677/joe.1.05762
pmcid: 15531721
Gabrielson M, Azam S, Hardell E, Holm M, Ubhayasekera KA, Eriksson M, Backlund M, Bergquist J, Czene K, Hall P (2020) Hormonal determinants of mammographic density and density change. Breast Cancer Res 22(1):95
pubmed: 32847607
pmcid: 7449090
doi: 10.1186/s13058-020-01332-4
D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA (2013) ACR BI-RADS® atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA
Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings SR, Miglioretti DL et al (2017) Combining quantitative and qualitative breast density measures to assess breast cancer risk. Breast Cancer Res 19(1):97
pubmed: 28830497
pmcid: 5567482
doi: 10.1186/s13058-017-0887-5
Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1048–1053
pubmed: 12376506
pmcid: 12376506
Bremnes Y, Ursin G, Bjurstam N, Gram IT (2007) Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study. Breast Cancer Res 9(5):R73
pubmed: 17963507
pmcid: 2242671
doi: 10.1186/bcr1782
Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54(3):1082–1090
pubmed: 21618575
doi: 10.1002/hep.24452
pmcid: 21618575
Sartor H, Lang K, Rosso A, Borgquist S, Zackrisson S, Timberg P (2016) Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists’ qualitative classification. Eur Radiol 26(12):4354–4360
pubmed: 27011371
pmcid: 5101269
doi: 10.1007/s00330-016-4309-3